Neuphoria Therapeutics Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
Neuphoria Therapeutics Inc. (NEUP) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of -27.60% for the 12-month period ending 2025-06-30, per its 10-K filed 2026-09-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2026-09-18
- Neuphoria Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2025 was -27.60%.
- Neuphoria Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2024 was -0.40%.
- Neuphoria Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2023 was -1.10%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month as first filed |
|---|---|---|
| 2025-06-30 | -27.60% 10-K · filed 2026-09-18 | |
| 2024-06-30 | -0.40% 10-K · filed 2025-09-29 | -0.30% 10-K · filed 2024-09-30 |
| 2023-06-30 | -1.10% 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |